Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
ARCUTIS BIOTHERAPEUTICS INC
About ARQT
Arcutis Biotherapeutics, Inc. is a commercial-stage medical dermatology company. The Company develops therapies against biologically validated targets and produces a pipeline for a range of inflammatory dermatological conditions. Its portfolio consists of topical and systemic treatments to treat immune-mediated dermatological diseases and conditions. Its product portfolio includes ZORYVE Roflumilast Cream, ZORYVE Roflumilast Foam, and ARQ-234. The ZORYVE Roflumilast Cream is used for the treatment of seborrheic dermatitis in individuals aged 9 years and older. The ZORYVE Roflumilast Foam for the topical treatment of mild to moderate atopic dermatitis in adults and pediatric patients 6 years of age and older. The ARQ-234 is a fusion protein that is a checkpoint agonist of the CD200 Receptor (CD200R). CD200R is an immune-regulatory receptor which is an immunological checkpoint with a role in the maintenance of immune tolerance.
Find out what a historical investment in ARCUTIS BIOTHERAPEUTICS INC would be worth today using our ARQT stock calculator.
Market Capitalisation
$2.44B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.33M
High today
$20.76
Low today
$19.65
Open price
$19.65
52-week high
$31.77
52-week low
$12.72
Ready to start your investing journey with Stake?
Open an accountHow do I buy ARQT shares in Australia?
Buying ARQT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ARCUTIS BIOTHERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ARQT
What is the ticker symbol of ARCUTIS BIOTHERAPEUTICS INC?
The ticker symbol for ARCUTIS BIOTHERAPEUTICS INC is ARQT.
How much is one share of ARQT?
One share of ARQT is valued at $20.44 as of 21 May 2026.
What is the market capitalisation of ARCUTIS BIOTHERAPEUTICS INC ARQT?
As of 21 May 2026 ARCUTIS BIOTHERAPEUTICS INC has a market cap of $2.44B.
What is the 52-week high for ARCUTIS BIOTHERAPEUTICS INC stock?
The ARCUTIS BIOTHERAPEUTICS INC 52-week high stock price is $31.77.
What is the 52-week low for ARCUTIS BIOTHERAPEUTICS INC stock?
The ARCUTIS BIOTHERAPEUTICS INC 52-week low stock price is $12.72.
Can I buy ARQT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ARQT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ARQT on Stake
- Buy ARQT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ARQT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ARQT related stocks